Detalles de la búsqueda
1.
The impact of proton-pump inhibitors administered with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma.
Anticancer Drugs
; 34(1): 178-186, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36539370
2.
Progression after First-Line Cyclin-Dependent Kinase 4/6 Inhibitor Treatment: Analysis of Molecular Mechanisms and Clinical Data.
Int J Mol Sci
; 24(19)2023 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37833875
3.
The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective study.
Ther Adv Urol
; 15: 17562872231187216, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37492625
4.
Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell carcinoma: does it affect outcome?
Expert Rev Anticancer Ther
; 23(5): 545-554, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37017710
Resultados
1 -
4
de 4
1
Próxima >
>>